CRO pay incentives lag behind other industries
Annual and long-term pay incentives at clinical research organisations (CROs) lag behind those in other industries, the latest edition of a CRO compensation survey has found.
Read MoreAuthor: Peter Mansell
NIH launches NIH Stroke Trials Network
The US National Institutes of Health (NIH) has set up a network of regional stroke centres to streamline research and clinical trials in the field.
Read MoreQuotient Clinical takes private equity route
Quotient Clinical has joined other providers of outsourced development services, such as PPD, PRA International, ReSearch Pharmaceutical Services and Theorem Clinical Research, in staking its future on private-equity ownership.
Read MoreIMI to test new approach to Alzheimer’s trials
The Innovative Medicines Initiative (IMI), the public-private partnership between the European Union and member companies of the European Federation of Pharmaceutical Industries and Associations, has launched a €53 million project to consolidate proof-of-concept trials of drugs for Alzheimer’s disease.
Read MoreMore money for neglected-disease R&D but public, PDP funds wane
Global funding for neglected-disease research and development reached US$3.2 billion (inflation-adjusted, reported in 2007 US dollars) in 2012, with a 3.2% or US$92.1 million increase in investment from repeat participants in the annual G-FINDER survey.
Read More- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
